Coya Therapeutics Ratios (2022-2025) | COYA

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 30.24%-3,982.96%-84.42%-209,031.51%-2,833.35%-3,725.17%-68.26%
EBIT Margin 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%
EBITDA Margin 30.36%-4,317.45%-94.28%-208,681.10%-2,974.24%-3,916.29%-68.07%
Operating Margin 30.24%-4,322.84%-94.48%-209,031.51%-2,976.89%-3,920.47%-68.26%
Net Margin 30.24%-3,982.96%-84.42%-209,031.51%-2,833.35%-3,725.17%-68.26%
FCF Margin -37.34%1,691.82%-133.23%-123,451.18%-1,096.72%-3,528.56%-31.72%
Efficiency
Assets Average 12.91M15.94M13.18M26.58M39.33M38.67M37.75M39.95M41.38M35.93M32.75M
Equity Average 3.88M14.70M11.67M22.86M34.01M33.82M33.63M35.79M36.47M30.84M27.80M
Invested Capital -8.39M16.15M13.25M10.09M35.64M32.39M35.26M32.01M39.58M33.37M28.31M27.28M
Asset Utilization Ratio 0.230.160.250.250.090.090.010.12
Leverage & Solvency
Equity Ratio -1.000.930.920.850.860.870.880.900.890.870.850.85
Valuation
Enterprise Value -5.93M-16.32M-13.10M-10.89M-32.63M-36.00M-36.60M-31.10M-38.34M-35.53M-29.80M-28.13M
Return Ratios
Return on Sales 0.30%-39.83%-0.84%-1.11%-2,090.32%-28.33%-37.25%-0.68%
Return on Capital Employed -0.37%-0.30%-0.30%-0.32%-0.48%-0.53%-0.72%-0.71%
Return on Assets -0.22%-0.39%-0.74%-0.30%-0.26%-0.25%-0.28%-0.41%-0.45%-0.61%-0.61%
Return on Equity -0.75%-0.42%-0.83%-0.35%-0.30%-0.29%-0.31%-0.46%-0.51%-0.71%-0.72%